TSG101: A novel anti-HIV-1 drug target

Current Medicinal Chemistry

Volumn 17, Issue 8, 2010, Pages 750-758

  Chen, Hongfei ^a   Liu, Xinyong ^a   Li, Zhenyu ^a   Zhan, Peng ^a   De Clercq, Erik ^b  

^a SHANDONG UNIVERSITY   (China)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Budding; Cyclic peptide; HIV 1; Inhibitors; Peptoid; PTAP; TSG101; UEV

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CELL PROTEIN; CYCLOPEPTIDE; PROTEIN INHIBITOR; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL VACUOLE; CRYSTAL STRUCTURE; GENE TARGETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIFE CYCLE; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; UBIQUITINATION; VIRION; VIRUS LIKE AGENT; VIRUS PARTICLE;

ANTI-HIV AGENTS; DNA-BINDING PROTEINS; DRUG DESIGN; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; HUMANS; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTORS;

EID: 77950639336     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710790514444     Document Type: Review

References (46)

1. Bonfanti, P.; Capetti, A.; Rizzardini, G. HIV disease treatment in the era of HAART. Biomed. Pharmacother., 1999, 53, 93-105. (Pubitemid 29356461)
2. De Clercq, E. The design of drugs for HIV and HCV. Nat. Rev. Drug Discov., 2007, 6, 1001-1018
3. Demonté, D.; Quivy, V.; Colette, Y.; Van, L.C. Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs: implications for the development of therapeutic strategies. Biochem. Pharmacol., 2004, 68, 1231-1238 (Pubitemid 39094289)
4. Freed, E.O. Viral late domains. J. Virol., 2002, 76, 4679-4687
5. Brass, A.L.; Dykxhoorn, D.M.; Benita, Y.; Yan, N.; Engelman, A.; Xavier, R.J.; Lieberman, J.; Elledge, S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science, 2008, 319, 921-926
6. Zhou, H.; Xu, M.; Huang, Q.; Gates, A.T.; Zhang, X.D.; Castle, J.C.; Stec, E.; Ferrer, M.; Strulovici, B.; Hazuda, D.J, Espeseth, A.S. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe, 2008, 4, 495-504.
7. Ott, D.E. Cellular proteins detected in HIV-1. Rev. Med. Virol., 2008, 18, 159-175
8. Carter, C.A. Tsg101: HIV-1's ticket to ride. Trends Microbiol., 2002, 10, 203-205
9. Martin-Serrano, J.; Zang, T.; Bieniasz, P.D. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med., 2001, 7, 1313-1319
10. Bieniasz, P.D. Late budding domains and host proteins in enveloped virus release. Virology, 2006, 344, 55-63.
11. Morita, E.; Sandrin, V.; Alam, S.L.; Eckert, D.M.; Gygi, S.P.; Sundquist, W.I. Identification of human MVB12 proteins as ESCRT-I subunits that function in HIV budding. Cell Host Microbe, 2007, 2, 41-53.
12. Freed, E.O. The HIV-TSG101 interface: recent advances in a budding field. Trends Microbiol., 2003, 11, 56-59 (Pubitemid 36207497)
13. Garrus, J.E.; von Schwedler, U.K.; Pornillos, O.W.; Morham, S.G.; Zavitz, K.H.; Wang, H.E.; Wettstein, D.A.; Stray, K.M.; Côté, M.; Rich, R.L.; Myszka, D.G.; Sundquist, W.I. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell, 2001, 107, 55-65. (Pubitemid 32972037)
14. Perez, O.D.; Nolan, G.P. Resistance is futile: assimilation of cellular machinery by HIV-1. Immunity, 2001, 15, 687-690
15. Watanabe, M.; Yanagi, Y.; Masuhiro, Y.; Yano, T.; Yoshikawa, H.; Yanagisawa, J.; Kato, S. A putative tumor suppressor, TSG101, acts as a transcriptional suppressor through its coiled-coil domain. Biochem. Biophys. Res. Commun., 1998, 245, 900-905 (Pubitemid 28414015)
16. Li, L.; Cohen, S.N. TSG101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell, 1996, 85, 319-329
17. McDonald, B.; Martin-Serrano, J. Regulation of Tsg101 expression by the steadiness box: a role of Tsg101-associated ligase. Mol. Biol. Cell, 2008, 19, 754-763 (Pubitemid 351272162)
18. Teo, H.; Gill, D.J.; Sun, J.; Perisic, O.; Veprintsev, D.B.; Vallis, Y.; Emr, S.D.; Williams, R.L. ESCRT-I core and ESCRT-II GLUE domain structures reveal role for GLUE in linking to ESCRT-I and membranes. Cell, 2006, 7, 125, 99-111.
19. Stuffers, S.; Brech, A.; Stenmark, H. ESCRT proteins in physiology and disease. Exp. Cell Res., 2009, 315, 1619-1626
20. Grigorov, B.; Arcanger, F.; Roingeard, P.; Darlix, J.L.; Muriaux, D. J. Assembly of infectious HIV-1 in human epithelial and Tlymphoblastic cell lines. Mol. Biol., 2006, 359, 848-862
21. Jouvenet, N.; Neil, S.J.; Bess, C.; Johnson, M.C.; Virgen, C.A.; Simon, S.M.; Bieniasz, P.D. Plasma membrane is the site of productive HIV-1 particle assembly. PLoS. Biol., 2006, 4, e435.
22. Finzi, A.; Orthwein, A.; Mercier, J.; Cohen, EA. Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. J. Virol., 2007, 81, 7476-7490
23. Ott, D.E. Potential roles of cellular proteins in HIV-1. Rev. Med. Virol., 2002, 12, 359-374
24. Bukrinskaya, A.G. HIV-1 assembly and maturation. Arch. Virol., 2004, 149, 1067-1082
25. Adamson, C.S.; Jones, I.M. The molecular basis of HIV capsid assembly-five years of progress. Rev. Med. Virol., 2004, 14, 107-121
26. Verani, A.; Gras, G.; Pancino, G. Macrophages and HIV-1: dangerous liaisons. Mol. Immunol., 2005, 42, 195-212.
27. Raiborg, C.; Rusten, T.E.; Stenmark, H. Protein sorting into multivesicular endosomes. Curr. Opin. Cell Biol., 2003, 15, 446-455
28. Pornillos, O.; Higginson, D.S.; Stray, K.M.; Fisher, R.D.; Garrus, J.E.; Payne, M.; He, G.P.; Wang, H.E.; Morham, S.G.; Sundquist, W.I. HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein. J. Cell Biol., 2003, 162, 425-434
29. Babst, M.; Katzmann, D.J.; Snyder, W.B.; Wendland, B.; Emr, S.D. Endosome-associated complex, ESCRT-II, recruits transport machinery for protein sorting at the multivesicular body. Dev. Cell, 2002, 3, 283-289
30. Muzioł, T.; Pineda-Molina, E.; Ravelli, R.B.; Zamborlini, A.; Usami, Y.; Göttlinger, H.; Weissenhorn, W. Structural basis for budding by the ESCRT-III factor CHMP3. Dev. Cell, 2006, 10, 821-830 (Pubitemid 43779119)
31. Demirov, D.G.; Freed, E.O. Retrovirus budding. Virus Res., 2004, 106, 87-102.
32. Welsch, S.; Müller, B.; Kräusslich, H.G. More than one door - Budding of enveloped viruses through cellular membranes. FEBS. Lett., 2007, 581, 2089-2097
33. Fisher, R.D.; Chung, H.Y.; Zhai, Q.; Robinson, H.; Sundquist, W.I.; Hill, C.P. Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell, 2007, 128, 841-852
34. Kostelansky, M.S.; Sun, J.; Lee, S.; Kim, J.; Ghirlando, R.; Hierro, A.; Emr, S.D.; Hurley, J.H. Structural and functional organization of the ESCRT-I trafficking complex. Cell, 2006, 125, 113-126
35. von Schwedler, U.K.; Stuchell, M.; Müller, B.; Ward, D.M.; Chung, H.Y.; Morita, E.; Wang, H.E.; Davis, T.; He, G.P.; Cimbora, D.M.; Scott, A.; Kräusslich, H.G.; Kaplan, J.; Morham, S.G.; Sundquist, W.I. The protein network of HIV budding. Cell, 2003, 114, 701-713
36. Strack, B.; Calistri, A.; Craig, S.; Popova, E.; Göttlinger, H.G. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell, 2003, 114, 689-699
37. Liu, F.L.; Fu, S.B.; Li, P. Advances in TSG101 gene. Int. J. Genet., 2007, 30, 14-18
38. Feng, Q.; Feng, Z.H.; Yu, Y.N. The study progress of tumor sensitive gene TSG101 in molecular biology. Carcino. Terato. Muta., 1999, 11, 151-153
39. Pornillos, O.; Alam, S.L.; Rich, R.L.; Myszka, D.G.; Davis, D.R.; Sundquist, W.I. Structure and functional interactions of the Tsg101 UEV domain. EMBO J., 2002, 21, 2397-2406
40. Palencia, A.; Martinez, J.C.; Mateo, P.L.; Luque, I.; Camara-Artigas, A. Structure of human TSG101 UEV domain. Acta. Crystallogr. D. Biol. Crystallogr., 2006, 62, 458-464
41. Pornillos, O.; Alam, S.L.; Davis, D.R.; Sundquist, W.I. Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat. Struct. Biol., 2002, 9, 812-817
42. Liu, F.; Stephen, A.G.; Adamson, C.S.; Gousset, K.; Aman, M.J.; Freed, E.O.; Fisher, R.J.; Burke, T.R. Jr. Hydrazone- and hydrazide-containing N-substituted glycines as peptoid surrogates for expedited library synthesis: application to the preparation of Tsg101- directed HIV-1 budding antagonists. Org. Lett., 2006, 8, 5165-5168
43. Kruijtzer, J.A.; Nijenhuis, W.A.; Wanders, N.; Gispen, W.H.; Liskamp, R.M.; Adan, R.A. Peptoid-peptide hybrids as potent novel melanocortin receptor ligands. J. Med. Chem., 2005, 48, 4224-4230 (Pubitemid 40884925)
44. Liu, F.; Stephen, A.G.; Fisher, R.J.; Burke, T.R. Jr. Protected aminooxyprolines for expedited library synthesis: application to Tsg101-directed proline-oxime containing peptides. Bioorg. Med. Chem. Lett., 2008, 18, 1096-1101
45. Naumann, T.A.; Savinov, S.N.; Benkovic, S.J. Engineering an affinity tag for genetically encoded cyclic peptides. Biotechnol. Bioeng., 2005, 92, 820-830
46. Tavassoli, A.; Lu, Q.; Gam, J.; Pan, H; Benkovic, S.J.; Cohen, S.N. Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction. ACS Chem. Biol., 2008, 3, 757-764